Circular RNA hsa_circ_0049657 as a Potential Biomarker in Non-Small Cell Lung Cancer

Simple Summary This study found that hsa_circ_0049657, a circular RNA derived from the NFIX gene, was down-regulated in NSCLC tissues and cells. In addition, we could suppress the proliferation and invasion abilities and promote apoptosis of NSCLC cells by up-regulating hsa_circ_0049657. Abstract Non-small cell lung cancer (NSCLC) is a common lung disorder. In this study, we applied bioinformatics methods to analyze and investigate the role of the NFIX gene in NSCLC. Hsa_circ_0049657 is derived from the NFIX gene, this research aimed to verify the potential role of hsa_circ_0049657 in the development of NSCLC. The results suggested that NFIX was downregulated in most cancers. In addition, the NFIX expression in lung adenocarcinoma (LUAD) was associated with the clinicopathological stage. In LUAD, NFIX expression was associated with the degree of infiltration of most immune cells. The expression levels of hsa_circ_0049657 were significantly lower in cancerous tissues than in paracancerous tissues. Moreover, the results showed that hsa_circ_0049657 expression was downregulated in NSCLC cells. After overexpression of hsa_circ_0049657, the proliferation and migration ability of NSCLC cells were significantly inhibited and the level of apoptosis was increased. We could suppress the proliferation and invasion abilities and promote apoptosis of NSCLC cells by up-regulating hsa_circ_0049657, which might be a potential biomarker for NSCLC.

[1]  A. R. Carlos,et al.  NFIXing Cancer: The Role of NFIX in Oxidative Stress Response and Cell Fate , 2023, International journal of molecular sciences.

[2]  Sumei Wang,et al.  The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers , 2022, Frontiers in Immunology.

[3]  Caicun Zhou,et al.  Non‐small cell lung cancer in China , 2022, Cancer communications.

[4]  M. Taheri,et al.  Circ_CDR1as: A circular RNA with roles in the carcinogenesis. , 2022, Pathology, research and practice.

[5]  Lu Gan,et al.  Checkpoint Inhibitor Pneumonitis Induced by Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer: Occurrence and Mechanism , 2022, Frontiers in Immunology.

[6]  F. Bi,et al.  Ferroptosis in the tumor microenvironment: perspectives for immunotherapy. , 2021, Trends in molecular medicine.

[7]  Dawei Sun,et al.  CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis , 2021, Frontiers in Oncology.

[8]  Q. Zhang,et al.  Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management , 2021, Frontiers in Immunology.

[9]  N. Almog,et al.  Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. , 2021, Cancer cell.

[10]  Kangdong Liu,et al.  A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy , 2021, Frontiers in Immunology.

[11]  J. Joyce,et al.  Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.

[12]  N. Siemers,et al.  Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment. , 2021, Annual review of immunology.

[13]  Jianguo Wang,et al.  Targeting tumor-associated macrophages to synergize tumor immunotherapy , 2021, Signal Transduction and Targeted Therapy.

[14]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[15]  S. Loi,et al.  Intratumoral heterogeneity in cancer progression and response to immunotherapy , 2021, Nature Medicine.

[16]  C. Jin,et al.  Unexpected guests in the tumor microenvironment: microbiome in cancer , 2020, Protein & cell.

[17]  Jia Liu,et al.  MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX , 2020, Cancer cell international.

[18]  Dihua Yu,et al.  Tumor microenvironment as a therapeutic target in cancer. , 2020, Pharmacology & therapeutics.

[19]  J. Rathmell,et al.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. , 2020, Molecular cell.

[20]  Jingli Tao,et al.  Nuclear factor IX promotes glioblastoma development through transcriptional activation of Ezrin , 2020, Oncogenesis.

[21]  Deepak Kgk,et al.  Tumor Microenvironment: Challenges and Opportunities in Targeting Metastasis of Triple Negative Breast Cancer. , 2020, Pharmacological research.

[22]  Liang Huang,et al.  Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. , 2019, European review for medical and pharmacological sciences.

[23]  Yiguo Jiang,et al.  Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer , 2019, Molecular Cancer.

[24]  Qingchuan Zhao,et al.  miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer , 2017, Molecular medicine reports.

[25]  P. Li,et al.  Characterization of hsa_circ_0004277 as a New Biomarker for Acute Myeloid Leukemia via Circular RNA Profile and Bioinformatics Analysis , 2017, International journal of molecular sciences.

[26]  Baosheng Li,et al.  MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC). , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  L. Richards,et al.  NFIX Regulates Proliferation and Migration Within the Murine SVZ Neurogenic Niche. , 2015, Cerebral cortex.

[28]  R. Gronostajski,et al.  Nuclear factor one transcription factors: Divergent functions in developmental versus adult stem cell populations , 2015, Developmental dynamics : an official publication of the American Association of Anatomists.

[29]  R. Matusik,et al.  NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression. , 2014, Molecular endocrinology.

[30]  R. Gronostajski,et al.  Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle , 2010, Cell.

[31]  G. Lyons,et al.  Essential Role for NFI-C/CTF Transcription-Replication Factor in Tooth Root Development , 2003, Molecular and Cellular Biology.

[32]  R. Gronostajski,et al.  Nuclear Factor One X in Development and Disease. , 2019, Trends in cell biology.

[33]  Li Yang,et al.  miR-210 promotes progression of endometrial carcinoma by regulating the expression of NFIX. , 2018, International journal of clinical and experimental pathology.